Additionally, circCCAR1, encapsulated within hepatocellular carcinoma (HCC)-derived EVs, is internalized by CD8 + T cells to stabilize PD-1 expression, thereby promoting resistance to anti-PD-1 immunotherapy [94]. This evidence concerns the gene CD8A and hepatocellular carcinoma.